The estimated Net Worth of Anne Virginie Eggimann is at least $31.2 millier dollars as of 12 July 2022. Ms Eggimann owns over 1,358 units of Bluebird bio Inc stock worth over $24,506 and over the last 4 years she sold BLUE stock worth over $6,722.
Ms has made over 1 trades of the Bluebird bio Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 1,358 units of BLUE stock worth $6,722 on 12 July 2022.
The largest trade she's ever made was selling 1,358 units of Bluebird bio Inc stock on 12 July 2022 worth over $6,722. On average, Ms trades about 340 units every 0 days since 2021. As of 12 July 2022 she still owns at least 42,252 units of Bluebird bio Inc stock.
You can see the complete history of Ms Eggimann stock trades at the bottom of the page.
Anne-Virginie Eggimann M.Sc. is the Chief Regulatory Officer at Bluebird bio Inc.
Anne's mailing address filed with the SEC is C/O BLUEBIRD BIO, INC., 455 GRAND UNION BOULEVARD, SOMERVILLE, MA, 02145.
Over the last 11 years, insiders at Bluebird bio Inc have traded over $130,743,125 worth of Bluebird bio Inc stock and bought 6,469 units worth $399,874 . The most active insiders traders include Steven Gillis, John Maraganore et Robert I Tepper. On average, Bluebird bio Inc executives and independent directors trade stock every 8 days with the average trade being worth of $6,033. The most recent stock trade was executed by Thomas J Klima on 3 June 2024, trading 3,834 units of BLUE stock currently worth $3,719.
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.
Bluebird bio Inc executives and other stock owners filed with the SEC include: